Navigation Links
Aethlon Medical to Present at Today's Southern California Investor Conference
Date:8/18/2009

SAN DIEGO, Aug. 18 /PRNewswire-FirstCall/ -- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD) announced that it will present at today's 14th Annual Southern California Investor Conference being held at the Island Hotel in Newport Beach, California. The conference is hosted by California Equity Research and highlights growth companies located in the region, including world-recognized life science, technology, media, and real estate/financial organizations. Aethlon Medical Chairman and CEO, Jim Joyce will present at 2:15 p.m. Pacific time followed by a break-out session and one-on-one meetings. For more information on the Southern California Investor Conference, please visit the conference website at www.californiastocks.com or call the conference desk at (858) 829-8688.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090325/LA88762LOGO-b)

About Aethlon Medical

Aethlon Medical creates diagnostic and therapeutic device solutions for infectious disease and cancer. Our Hemopurifier(R) represents the first-in-class medical device to selectively adsorb viruses and immunosuppressive toxins from the bloodstream. The Hemopurifier(R) seeks to improve Hepatitis-C treatment outcomes and serves as a broad-spectrum treatment countermeasure against bioterror and pandemic threats. Additional information regarding Aethlon Medical can be accessed online at www.aethlonmedical.com.

    Contacts:

    Jon Cunningham
    RedChip Companies Inc.
    (407) 644-4256
    (407) 491-4498 -cell
    www.redchip.com
    Jon@redchip.com

    Jim Joyce
    Chairman, CEO
    858.459.7800 x301
    jj@aethlonmedical.com

    Jim Frakes
    Senior VP Finance
    858.459.7800 x300
    jfrakes@aethlonmedical.com

Certain of the statements herein may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such potential risks and uncertainties include, without limitation, the capability of the Hemopurifier(R) to reduce viral loads and other disease conditions, the Company's ability to complete the development of its planned products, the ability of the Company to obtain FDA and other regulatory approvals permitting the sale of its products, the Company's ability to manufacture its products and provide its services, the impact of government regulations, patent protection on the Company's proprietary technology, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings.


'/>"/>
SOURCE Aethlon Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Aethlon Medical Announces CEO Interview and Corporate Presentation Available Online
2. Aethlon Medical Announces Engagement of RedChip Companies to Initiate Investor and Media Relations Programs
3. Aethlon Medical Confirms Hemopurifier(R) Is a Treatment Candidate Against Swine Flu Virus
4. Aethlon Medical Discloses New HIV/AIDS Treatment Data
5. Aethlon Medical Releases Shareholder Letter to Discuss the Treatment of Hepatitis-C Virus (HCV)
6. Aethlon Medical Announces U.S. Army Agreement
7. Aethlon Medical Initiates Swine Flu Testing Program
8. MSU engineering team designs innovative medical device
9. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
10. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
11. Owner and Operator of Florida Durable Medical Equipment Company Convicted of Medicare Fraud
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... ?This conference will prominently feature 150+ Hospital and Health System Executive ... Healthcare: Susan Salka , 43rd President of the United States of America: George ... Life In and Out of the Ring: Sugar Ray Leonard , JD, Chairperson, ...
(Date:3/23/2017)... OR (PRWEB) , ... March 23, 2017 , ... Sharon ... Water, Global Climate Change and Your Health on VoiceAmerica, recently talked on her program ... she also used the occasion to remind listeners of an important distinction. World Water ...
(Date:3/23/2017)... Boca Raton, FL (PRWEB) , ... March 23, ... ... range of dietary supplements that help improve all aspects of people’s health and ... popular website for nutritional products. , Natural Subsistence develops nutritional supplements that ...
(Date:3/23/2017)... ... March 23, 2017 , ... Inflow IQ & Inflownomics of Raleigh, NC ... on a solid foundation. As experts in dangerous situations the Inflow IQ team ... soon. Inflownomics deliver ripe, fresh, clean & refreshing knowledge systems that enhance life. ...
(Date:3/23/2017)... New Port Richey, FL (PRWEB) , ... March 23, 2017 , ... ... delighted to announce that 2017 marks the 40th Anniversary of ABQAURP’s dedication to Health ... that ABQAURP honors those who have contributed not only to the association, but also ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... /PRNewswire/ - Medicure Inc. ("Medicure" or the "Company") ... is pleased to announce that its majority-owned subsidiary, ... U.S. Food and Drug Administration (FDA) for the ... tablets in the 12.5 mg and 25 mg ... equivalent of the branded product Xenazine ® ...
(Date:3/23/2017)... ReNeuron reported in December 2016 positive ... stroke patients, despite not meeting the three-month time frame of ... Research Arm Test (ARAT). As a result, the company has ... study in 2017. Beyond CTX, we expect safety and efficacy ... Phase I data from its critical limb ischaemia (CLI) trial. ...
(Date:3/23/2017)... , Mar 23, 2017 The Board ... to the Annual General Meeting, which is to take place on ... 2 in Lund, Sweden . ... Please see the attached notification, which ... Inrikes Tidningar. NeuroVive Pharmaceutical AB (Publ) The Board Of ...
Breaking Medicine Technology: